chr11-5226955-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PM5
The NM_000518.5(HBB):c.67G>A(p.Glu23Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E23A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.67G>A | p.Glu23Lys | missense_variant | 1/3 | ENST00000335295.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.67G>A | p.Glu23Lys | missense_variant | 1/3 | 1 | NM_000518.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152234Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461552Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727110
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74508
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 06, 2022 | The Hb E-Saskatoon variant (HBB: c.67G>A, p.Glu23Lys, also known as Glu22Lys when numbered from the mature protein, rs33959855, HbVar ID: 264) has been reported in a heterozygous state in individuals with no clinical symptoms (HbVar database and reference therein), and comprises half of the total hemoglobin (Birben 2001). Individuals carrying the variant in-trans to Hb S or a beta thalassemia pathogenic variant exhibit mild-moderate hematological abnormalities (Birben 2001, Couto 2014, Theodoridou 2003, HbVar database and references therein), while a homozygous individual presented only mild anemia (Birben 2001). The variant is listed in ClinVar (Variation ID: 15162), but is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. The at codon 23 is highly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.536). Although Hb E-Saskatoon has not been associated with severe hematological symptoms, it has been associated with mild hematological changes in combination with other variants; overall, its clinical significance cannot be determined with certainty. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Birben E et al. Homozygosity for Hb E-Saskatoon (beta22(B4)Glu-->Lys) in a Turkish patient. Hemoglobin. 2001; 25(4):409-15. PMID: 11791874. Couto GK et al. Association of hemoglobin E-Saskatoon with hemoglobin S: report of the first case found in Brazil. Acta Haematol. 2014;131(2):84-7. PMID: 24081202. Theodoridou S et al. The first case of a compound heterozygosity for Hb E-Saskatoon and HbS. Haematologica. 2003 Mar;88(3):ECR08. PMID: 12651286. - |
HEMOGLOBIN E (SASKATOON) Other:1
other, no assertion criteria provided | literature only | OMIM | Nov 14, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at